Data advancements are finally unlocking drug safety during pregnancy
By Meg Richards, PhD, MPH, Executive Director, Strategic Solutions & Consulting Services, Panalgo
Check out Panalgo thought leadership articles to see our experts' takes on important topics in the healthcare analytics industry.
By Meg Richards, PhD, MPH, Executive Director, Strategic Solutions & Consulting Services, Panalgo
By Meg Richards, PhD, MPH, Executive Director, Scientific Strategy at Panalgo, with Andrew Goldstein, VP of Client Partnerships at Panalgo
By Meg Richards, PhD, MPH Executive Director of Solutions, Panalgo With Mike Munsell, Director of Research, Panalgo
by Lucie Ellis-Taitt (Citeline)
by Dr Samy Suissa (McGill University, CNODES) and Meg Richards (Panalgo)
By Chao Li, PhD, Data Scientist at AbbVie, and Mike Munsell, Director of Research at Panalgo
Applied Clinical Trials article from Panalgo's Executive Director of Solutions Engineering, Meg Richards, PhD.
Pharmacy Times article with Solutions Engineer Matthew Marshall on how payors can leverage RWD analytics.
Chris Harvey and Carolyn Zele discuss the insights that health economics and outcomes research (HEOR) professionals bring to commercial teams. They explain how that pairing benefits both manufacturers and patients.
Healthcare Business Today article from Zeynep Icten, PhD, Director of Data Science Solutions at Panalgo.
HIT Consultant article from Zeynep Icten, PhD, Director of Data Science Solutions at Panalgo.
HIT Consultant article from Director of Analytics Solutions, Tiffany Siu Woodworth, MBA, MPH.
Article in Health IT Answers by Catherine Richards, PhD, MPH - Senior Vice President of Analytics and Scientific Engagement at Panalgo.
Article in Life Science Leader by Catherine Richards, PhD, MPH - Senior Vice President of Analytics and Scientific Engagement at Panalgo.
Scientific American article by Panalgo CEO, Joseph Menzin, PhD, and Panalgo Strategic Advisory Board member, Peter Neumann, ScD.
Life Science Leader article from VP of Modeling & Evidence, Matt Sussman.
Joseph Menzin, PhD, discusses the risks and rewards of fast-tracked COVID-19 studies.
Matthew Sussman, BHE's VP of Modeling & Strategy Services, discusses the use of remdesivir for COVID-19 patients and the risks and rewards of fast tracking value-based drug evaluations.
Healthcare IT Today article from Panalgo Founder and Executive Chairman, Joseph Menzin, PhD.
Interview on the future of the healthcare industry with Joseph Menzin, PhD.
Put reliable, rapid analytics in the hands of more people across your organization